Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Nymox Pharmaceutical Corp NYMXF

Healthcare Biotechnology
Nymox Pharmaceutical Corporation is a Canada-based biopharmaceutical company focused on developing its drug candidate, NX-1207, for treating benign prostatic hyperplasia (BPH) and low-grade localized prostate cancer. The Company’s activities and resources have been directed primarily at developing certain pharmaceutical technologies. Its products include Fexapotide Triflutate, NicAlert and... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (PINL:NYMXF)

Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees - Court Awards Costs and Damages

GlobeNewswire March 27, 2024

Nymox December 27 Message to Shareholders

GlobeNewswire December 27, 2023

Nymox Reports California Court Issues Preliminary Injunction Against Defendants Lanham, Riley, Cutler and Others

GlobeNewswire November 30, 2023

$250 Million Lawsuit Filed Against AscellaHealth by Nymox Accepted and Summons Issued in California Court

GlobeNewswire November 21, 2023

Nymox Pharmaceutical Corporation Sues AscellaHealth For $250 Million

GlobeNewswire November 9, 2023

NYMOX REPORTS: Bahamian Court Today Suspends Order of October 3, 2023 Rendering Riley-Lanham and Accomplices Planned Vote Unauthorized

GlobeNewswire November 3, 2023

NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023

GlobeNewswire November 3, 2023

IMPORTANT MESSAGE TO NYMOX SHAREHOLDERS: NYMOX Cautions Against Unauthorized Improper Shareholder Meeting and Unauthorized Unregistered Solicitations

GlobeNewswire November 2, 2023

IMPORTANT NOTICE: NYMOX Cautions Shareholders Not to Take Calls or Participate in Unauthorized Improper Shareholder Meeting

GlobeNewswire October 31, 2023
View More News ››

Opinion & Analysis (PINL:NYMXF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (PINL:NYMXF)

Good things coming

The stock had a strong run this past week on the heels of the 7th annual Singular Research Conference. I'm looking for a possible...
NGLsRgood$ - November 11, 2012

NX-1207 Outlook

Is anyone out there following this stock? Their phase 3 trials for NX-1207 appear to be getting favourable reviews  for the...
NGLsRgood$ - October 7, 2012

breakout

I think NYMX is getting ready for a breakout. By early 2010 we should be expecting  FDA marketing approval for NY-1207.......
NGLsRgood$ - July 17, 2011

**Contract news**

They finally got the big contract and no insider buying leading up to news. NEWS RELEASE TRANSMITTED BY CCNMatthews FOR...
classicact - October 21, 2004

more news

these anbody know more about this company
sbraca - June 14, 2001

opinion

It seems to me that this company is doing the right things but, they forget that the investment community need some results in dollars...
bébé - November 1, 2000
View more Bullboard ››

BioVaxys Technology Corp.

BioVaxys Technology Corp.

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving ...
View More »